1. Smyth, EC, Nilsson, M, Grabsch, HI, et al. Gastric cancer. Lancet 2020; 396: 635–648.
Google Scholar | Crossref | Medline2. Röcken, C . Molecular classification of gastric cancer. Expert Rev Mol Diagn 2017; 17: 293–301.
Google Scholar | Crossref | Medline3. Majeed, W, Iftikhar, A, Khaliq, T, et al. Gastric carcinoma: recent trends in diagnostic biomarkers and molecular targeted therapies. Asian Pac J Cancer Prev 2016; 17: 3053–3060.
Google Scholar | Medline4. Chia, NY, Tan, P. Molecular classification of gastric cancer. Ann Oncol 2016; 27: 763–769.
Google Scholar | Crossref | Medline5. Yamamoto, Y, Fujisaki, J, Omae, M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc 2015; 27: 551–561.
Google Scholar | Crossref | Medline6. Gong, X, Zhang, H. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19–9, and CEA for young patients with early gastric cancer. J Clin Lab Anal 2020; 34: e23268.
Google Scholar | Crossref | Medline7. Matsuo, T, Ito, M, Takata, S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 2011; 16: 415–419.
Google Scholar | Crossref | Medline8. Liu, C, Hu, C, Li, Z, et al. Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance. Cancer Cell Int 2020; 20: 279.
Google Scholar | Crossref | Medline9. Dong, L, Qi, P, Xu M, D, et al. Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls. Int J Cancer 2015; 137: 1128–1135.
Google Scholar | Crossref | Medline10. Venerito, M, Link, A, Rokkas, T, et al. Gastric cancer - clinical and epidemiological aspects. Helicobacter 2016; 1: 39–44.
Google Scholar | Crossref11. Zhang, J, Ding, Y, Wang, W, et al. Combining the fibrinogen/albumin ratio and systemic inflammation response index predicts survival in resectable gastric cancer. Gastroenterol Res Pract 2020; 2020: 3207345.
Google Scholar | Crossref | Medline12. Zhang, J, Li S, Q, Liao Z, H, et al. Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer. Oncotarget 2017; 8: 75195–75205.
Google Scholar | Crossref | Medline13. Zhang, X, Zhao, W, Chen, X, et al. Combining the fibrinogen-to-pre-albumin ratio and prognostic nutritional index (FPR-PNI) predicts the survival in elderly gastric cancer patients after gastrectomy. Onco Targets Ther 2020; 13: 8845–8859.
Google Scholar | Crossref | Medline14. Xu, Q, Yan, Y, Gu, S, et al. A novel inflammation-based prognostic score: the fibrinogen/albumin ratio predicts prognoses of patients after curative resection for hepatocellular carcinoma. J Immunol Res 2018; 2018: 4925498.
Google Scholar | Crossref | Medline15. Huang, L, Mo, Z, Hu, Z, et al. Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma. Cancer Cell Int 2020; 20: 77.
Google Scholar | Crossref | Medline16. Zang, S, Shi, L, Zhao, J, et al. Prealbumin to fibrinogen ratio is closely associated with diabetic peripheral neuropathy. Endocr Connect 2020; 9: 858–863.
Google Scholar | Crossref | Medline17. Han, WX, Chen, ZM, Wei, ZJ, et al. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction. World J Surg Oncol 2016; 14: 279.
Google Scholar | Crossref | Medline18. Wang, Y, Chen, W, Hu, C, et al. Albumin and fibrinogen combined prognostic grade predicts prognosis of patients with prostate cancer. J Cancer 2017; 8: 3992–4001.
Google Scholar | Crossref | Medline19. Palaj, J, Kečkéš, Š, Marek, V, et al. Fibrinogen levels are associated with lymph node involvement and overall survival in gastric cancer patients. Anticancer Res 2018; 38: 1097–1104.
Google Scholar | Medline20. Chen, LT, Oh, DY, Ryu, MH, et al. Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: a systematic review. Cancer Res Treat 2017; 49: 851–868.
Google Scholar | Crossref | Medline21. Feng, F, Tian, Y, Xu, G, et al. Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer. BMC Cancer 2017; 17: 737.
Google Scholar | Crossref | Medline22. Zhang, J, Ruan, J, Wang, W, et al. Prognostic value of the combination of CEA and fibrinogen/albumin ratio in resectable gastric cancer. Cancer Manag Res 2020; 12: 2767–2775.
Google Scholar | Crossref | Medline23. Ying, HQ, Liao, YC, Luo, YR, et al. Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC. Pharmacol Res 2021; 170: 105734.
Google Scholar | Crossref | Medline24. Valero, C, Lee, M, Hoen, D, et al. Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors. Nat Commun 2021; 12: 729.
Google Scholar | Crossref | Medline25. Gemenetzis, G, Bagante, F, Griffin J, F, et al. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2017; 266: 339–345.
Google Scholar | Crossref | Medline26. Ying, HQ, Sun, F, Liao, YC, et al. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer. Ther Adv Med Oncol 2021; 13: 17588359211022886.
Google Scholar | SAGE Journals27. Gao, ZM, Wang, RY, Deng, P, et al. TNM-PNI: a novel prognostic scoring system for patients with gastric cancer and curative D2 resection. Cancer Manag Res 2018; 10: 2925–2933.
Google Scholar | Crossref | Medline28. Wu, ZJ, Xu, H, Wang, R, et al. Cumulative score based on preoperative fibrinogen and pre-albumin could predict long-term survival for patients with resectable gastric cancer. J Cancer 2019; 10: 6244–6251.
Google Scholar | Crossref | Medline29. Huang, L, Mo, Z, Zhang, L, et al. Diagnostic value of albumin to fibrinogen ratio in cervical cancer. Int J Biol Markers 2020; 35: 66–73.
Google Scholar | SAGE Journals | ISI30. Sun, KY, Xu, JB, Chen, SL, et al. Novel immunological and nutritional-based prognostic index for gastric cancer. World J Gastroenterol 2015; 21: 5961–5971.
Google Scholar | Crossref | Medline31. Li, B, Liu, HY, Guo, SH, et al. Impact of early postoperative enteral nutrition on clinical outcomes in patients with gastric cancer. Genet Mol Res 2015; 14: 7136–7141.
Google Scholar | Crossref | Medline32. Gupta, D, Lis, CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 2010; 9: 69.
Google Scholar33. Huang, J, Wang, Y, Yuan, Y, et al. Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy. Oncotarget 2017; 8: 36772–36779.
Google Scholar | Crossref | Medline34. Yue, W, Liu, Y, Ding, W, et al. The predictive value of the prealbumin-to-fibrinogen ratio in patients with acute pancreatitis. Int J Clin Pract 2015; 69: 1121–1128.
Google Scholar | Crossref | Medline35. Sun, F, Tan, YA, Gao, QF, et al. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer. J Clin Lab Anal 2019; 33: e22635.
Google Scholar | Crossref | Medline36. Yang, WM, Zhang, WH, Ying, HQ, et al. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: albumin to fibrinogen ratio and C-reactive protein to albumin ratio. Int Immunopharmacol 2018; 62: 293–298.
Google Scholar | Crossref | Medline37. Sun, F, Peng, H-X, Gao, Q-F, et al. Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II-III colorectal cancer patients. Cancer Manag Res 2018; 10: 2151–2161.
Google Scholar | Crossref | Medline